Cargando…
Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells
Lung cancer remains one of the most common cancer-associated mortalities worldwide, and platinum-based doublet chemotherapies are recommended as the first-line treatment for advanced non-small cell lung cancer (NSCLC). However, the frequent development of multidrug resistance, to cisplatin regimens...
Autores principales: | He, Jinxi, Shi, Juan, Zhang, Kangjian, Xue, Jing, Li, Jing, Yang, Jiali, Chen, Juan, Wei, Jun, Ren, Hong, Liu, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365002/ https://www.ncbi.nlm.nih.gov/pubmed/28259951 http://dx.doi.org/10.3892/mmr.2017.6170 |
Ejemplares similares
-
Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a/PKC Signaling Pathway
por: Yang, Jiali, et al.
Publicado: (2016) -
Modulation of Wnt/β-catenin signaling in IL-17A-mediated macrophage
polarization of RAW264.7 cells
por: Yuan, Chao, et al.
Publicado: (2020) -
Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2
por: Sinha, Abhishek, et al.
Publicado: (2021) -
Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
por: Zheng, Jing-jing, et al.
Publicado: (2020) -
Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth
por: Uka, Rexhep, et al.
Publicado: (2020)